Advanced search
Publication Cover
Expert Opinion on Drug Metabolism & Toxicology Volume 18, 2022 - Issue 6
Submit an article Journal homepage
282
Views
7
CrossRef citations to date
0
Altmetric
Review

Counteracting heart failure with diabetes drugs: a review into the pharmacokinetic and pharmacodynamic properties

André J. Scheena Division of Clinical Pharmacology, Centre for Interdisciplinary Research on Medicines (CIRM), University of Liège, Liège, Belgium;b Division of Diabetes, Nutrition and Metabolic Disorders, Department of Medicine, CHU Liège, Liège, BelgiumCorrespondence[email protected]
View further author information
Pages 381-393 | Received 25 Feb 2022, Accepted 20 Jul 2022, Published online: 02 Aug 2022

Citations (7)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

André J. Scheen. (2023) The current role of SGLT2 inhibitors in type 2 diabetes and beyond: a narrative review. Expert Review of Endocrinology & Metabolism 18:4, pages 271-282.
Read now

Articles from other publishers (6)

André J. Scheen. (2023) Cardiovascular and renal outcomes with SGLT2 inhibitors: Real-life observational studies in older patients with type 2 diabetes. Diabetes Epidemiology and Management 10, pages 100135.
Crossref
André J. Scheen & Fabrice Bonnet. (2023) Efficacy and safety profile of SGLT2 inhibitors in the elderly: How is the benefit/risk balance?. Diabetes & Metabolism 49:2, pages 101419.
Crossref
André J. Scheen. (2022) Les inhibiteurs des SGLT2 réduisent le risque de fibrillation auriculaire, d’arythmies ventriculaires et de mort subite. Médecine des Maladies Métaboliques.
Crossref
Silvio E Inzucchi, Brian L Claggett, Muthiah Vaduganathan, Akshay S Desai, Pardeep S Jhund, Rudolf A de Boer, Adrian F Hernandez, Mikhail N Kosiborod, Carolyn S P Lam, Felipe Martinez, Sanjiv J Shah, Subodh Verma, Yaling Han, Jose F Kerr Saraiva, Olof Bengtsson, Magnus Petersson, Anna Maria Langkilde, John J V McMurray & Scott D Solomon. (2022) Efficacy and safety of dapagliflozin in patients with heart failure with mildly reduced or preserved ejection fraction by baseline glycaemic status (DELIVER): a subgroup analysis from an international, multicentre, double-blind, randomised, placebo-controlled trial. The Lancet Diabetes & Endocrinology 10:12, pages 869-881.
Crossref
André J. Scheen. (2022) Glucose-lowering agents and risk of ventricular arrhythmias and sudden cardiac death: A comprehensive review ranging from sulphonylureas to SGLT2 inhibitors. Diabetes & Metabolism 48:6, pages 101405.
Crossref
André J Scheen. (2022) Dissecting the reduction in cardiovascular death with SGLT2 inhibitors: Potential contribution of effects on ventricular arrhythmias and sudden cardiac death?. Diabetes Epidemiology and Management 8, pages 100107.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.